======= ANKRD33 =======
== Gene Information ==
* **Official Symbol**: ANKRD33
* **Official Name**: ankyrin repeat domain 33
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=341405|341405]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q7Z3H0|Q7Z3H0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ANKRD33&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANKRD33|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/620857|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Acts as a transcriptional repressor for CRX-activated photoreceptor gene regulation. {ECO:0000250|UniProtKB:Q8BXP5}.
|Ank|
|Ank 2|
|negative regulation of transcription regulatory region DNA binding|
|skeletal muscle cell differentiation|
|regulation of transcription regulatory region DNA binding|
|negative regulation of DNA binding|
|skeletal muscle tissue development|
|regulation of DNA binding|
|skeletal muscle organ development|
|negative regulation of binding|
|striated muscle tissue development|
|muscle organ development|
|muscle tissue development|
|regulation of binding|
|muscle structure development|
|negative regulation of transcription by RNA polymerase II|
|negative regulation of molecular function|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
|tissue development|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp90|WYE-354 6μM R02 exp90]]|-2.08|
|[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|-1.73|
|[[:results:exp232|Epothilone-D 0.004 to 0.006μM on day4 R05 exp232]]|1.96|
|[[:results:exp145|PNU96415E 10μM R03 exp145]]|1.99|
|[[:results:exp210|LB-100 2μM R05 exp210]]|2.14|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 13458
* **Expression level (log2 read counts)**: -3.08
{{:chemogenomics:nalm6 dist.png?nolink |}}